Human Tissue Microarray (BLA060-01B)
Bladder Urothelial Carcinoma Tumor Tissue Microarray. Single core per case
- 60 Urothelial carcinoma cases
- 1 Matched NAT
$225.00
| Species | Human |
|---|---|
| Section Thickness | 5 µm |
| Fixative | Formalin |
| Total Cases | 60 |
| Total Cores | 61 |
| Core Diameter | 1.5 mm |
| Storage | Short term RT; Long term 4ºC |
| Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- B
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- C
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- D
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- E
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- F
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
- BL
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
| No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
A1
|
M
|
80
|
Bladder
|
Urothelial Carcinoma
|
-
|
T4N2M0
|
IIIB
|
Malignant
|
509A-21
|
|
2
|
A2
|
F
|
50
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T4N1M0
|
-
|
Malignant
|
471266
|
|
3
|
A3
|
F
|
65
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T1N0M1
|
IV
|
Malignant
|
08-1896E
|
|
4
|
A4
|
F
|
70
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
17-6863C
|
|
5
|
A5
|
F
|
55
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T2N1M0
|
IV
|
Malignant
|
18-29351B
|
|
6
|
A6
|
M
|
61
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
18-7350E
|
|
7
|
A7
|
M
|
51
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
19-16140C
|
|
8
|
A8
|
M
|
84
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
20-3498C
|
|
9
|
A9
|
M
|
50
|
Bladder
|
Urothelial Carcinoma
|
-
|
T4N2M0
|
IIIB
|
Malignant
|
22H-2513A3
|
|
10
|
A10
|
M
|
78
|
Bladder
|
Urothelial Carcinoma
|
-
|
T4N0M0
|
IIIB
|
Malignant
|
230/22-2
|
|
11
|
B1
|
M
|
56
|
Bladder
|
Urothelial Carcinoma
|
-
|
T3N0M0
|
IIIA
|
Malignant
|
3747/21-2
|
|
12
|
B2
|
M
|
74
|
Bladder
|
Urothelial Carcinoma
|
-
|
T4N0M0
|
IIIB
|
Malignant
|
415/22-2
|
|
13
|
B3
|
M
|
67
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2aN0M0
|
II
|
Malignant
|
502-G/19/B
|
|
14
|
B4
|
M
|
55
|
Bladder
|
Urothelial Carcinoma
|
-
|
T4N0M0
|
IIIB
|
Malignant
|
664/22-2
|
|
15
|
B5
|
M
|
57
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN0M0
|
II
|
Malignant
|
695-J/21/C
|
|
16
|
B6
|
M
|
42
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN1M0
|
IIIA
|
Malignant
|
H17/14523
|
|
17
|
B7
|
M
|
54
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3bN1M0
|
IIIA
|
Malignant
|
H18/13896
|
|
18
|
B8
|
M
|
58
|
Bladder
|
Urothelial Carcinoma
|
-
|
T3N1M0
|
IIIA
|
Malignant
|
H18/21789
|
|
19
|
B9
|
M
|
59
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
H18/40656
|
|
20
|
B10
|
F
|
58
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN1M0
|
IIIA
|
Malignant
|
H18/51856
|
|
21
|
C1
|
M
|
46
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
H18/6852
|
|
22
|
C2
|
M
|
47
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3BN1M0
|
IIIA
|
Malignant
|
H19/24122
|
|
23
|
C3
|
M
|
45
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
H19/2751
|
|
24
|
C4
|
F
|
59
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN1M0
|
IIIA
|
Malignant
|
H19/39956
|
|
25
|
C5
|
F
|
56
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN0M0
|
II
|
Malignant
|
H19/7756
|
|
26
|
C6
|
M
|
62
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T4N1M0
|
IVA
|
Malignant
|
H20/16120
|
|
27
|
C7
|
M
|
58
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
H20/2116
|
|
28
|
C8
|
F
|
47
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN0M0
|
II
|
Malignant
|
H20/9952
|
|
29
|
C9
|
F
|
59
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN0M0
|
II
|
Malignant
|
HP-43652/21
|
|
30
|
C10
|
M
|
42
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
HP-8235/20
|
|
31
|
D1
|
M
|
53
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN2M0
|
IIIB
|
Malignant
|
HP-8564/19
|
|
32
|
D2
|
M
|
65
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3bN1M0
|
IIIA
|
Malignant
|
PS-18654/18
|
|
33
|
D3
|
M
|
55
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3aN2M0
|
IIIB
|
Malignant
|
PS-35642/19
|
|
34
|
D4
|
F
|
48
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN0M0
|
II
|
Malignant
|
PS-4757/18
|
|
35
|
D5
|
M
|
55
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN1M0
|
IIIA
|
Malignant
|
PS-7591/18
|
|
36
|
D6
|
M
|
59
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T3bN1M0
|
IIIA
|
Malignant
|
PS-9812/20
|
|
37
|
D7
|
M
|
79
|
Bladder
|
Urothelial Carcinoma
|
G2
|
T3N0M1
|
IV
|
Malignant
|
21111026A
|
|
38
|
D8
|
M
|
73
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21111028A
|
|
39
|
D9
|
M
|
75
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21111029A
|
|
40
|
D10
|
M
|
60
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112900A
|
|
41
|
E1
|
M
|
62
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112901A
|
|
42
|
E2
|
M
|
74
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112902A
|
|
43
|
E3
|
M
|
75
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112903A
|
|
44
|
E4
|
M
|
70
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112909A
|
|
45
|
E5
|
M
|
71
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112910A
|
|
46
|
E6
|
M
|
72
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N1M0
|
IV
|
Malignant
|
21112911A
|
|
47
|
E7
|
M
|
79
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112912B
|
|
48
|
E8
|
M
|
74
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112915A
|
|
49
|
E9
|
M
|
73
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112921A
|
|
50
|
E10
|
M
|
66
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112923B
|
|
51
|
F1
|
M
|
57
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N2M0
|
IV
|
Malignant
|
21112925A
|
|
52
|
F2
|
M
|
84
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112926A
|
|
53
|
F3
|
M
|
72
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T3N0M0
|
III
|
Malignant
|
21112927A
|
|
54
|
F4
|
M
|
65
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T2N1M0
|
-
|
Malignant
|
21113338A
|
|
55
|
F5
|
M
|
65
|
Bladder
|
Urothelial Carcinoma
|
G3
|
T2N1M0
|
-
|
Malignant
|
21113339A
|
|
56
|
F6
|
F
|
40
|
Bladder
|
Urothelial Carcinoma
|
G2
|
T3N0M0
|
-
|
Malignant
|
21113340A
|
|
57
|
F7
|
M
|
67
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2N0M0
|
II
|
Malignant
|
21113486A
|
|
58
|
F8
|
M
|
57
|
Bladder
|
Urothelial Carcinoma
|
HIGH
|
T2bN2M0
|
IIIB
|
Malignant
|
21113489A
|
|
59
|
F9
|
M
|
65
|
Bladder
|
Urothelial Carcinoma
|
-
|
-
|
-
|
Malignant
|
F03A0960
|
|
60
|
F10
|
F
|
68
|
Bladder
|
Urothelial Carcinoma
|
-
|
-
|
-
|
Malignant
|
F03A1068
|
|
61
|
F11
|
F
|
68
|
Bladder
|
F10 matched NAT
|
-
|
-
|
-
|
NAT
|
F03A1068
|
